Advisory Resource Group Pfizer Inc Transaction History

Advisory Resource Group

$414 Million
Q3 2024

A detailed history of Advisory Resource Group transactions in Pfizer Inc stock. As of the latest transaction made, Advisory Resource Group holds 7,220 shares of PFE stock, worth $191,979. This represents 0.05% of its overall portfolio holdings.

Number of Shares

7,220

Previous 8,649 16.52%

Holding current value

$191,979

Previous $241,000 13.69%

% of portfolio

0.05%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	SELL	$27.7 - $31.39 $39,583 - $44,856	-1,429 Reduced 16.52%	7,220 $208,000
Q2 2024 Jul 24, 2024	BUY	$25.26 - $29.6 $218,473 - $256,010	8,649 New	8,649 $241,000
Q4 2023 Jan 11, 2024	BUY	$26.13 - $33.94 $313 - $407	12 Added 0.17%	7,179 $206,000
Q3 2023 Dec 05, 2023	SELL	$32.09 - $37.51 $60,361 - $70,556	-1,881 Reduced 20.79%	7,167 $237,000
Q2 2023 Jul 11, 2023	BUY	$36.12 - $41.79 $5,851 - $6,769	162 Added 1.82%	9,048 $331,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $512 - $666	13 Added 0.15%	8,886 $362,000
Q4 2022 Jan 27, 2023	SELL	$41.75 - $54.5 $5,803 - $7,575	-139 Reduced 1.54%	8,873 $0
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $3,850 - $4,700	-88 Reduced 0.97%	9,012 $394,000
Q2 2022 Jul 21, 2022	BUY	$46.53 - $55.17 $5,118 - $6,068	110 Added 1.22%	9,100 $477,000
Q1 2022 Apr 06, 2022	BUY	$45.75 - $56.69 $503 - $623	11 Added 0.12%	8,990 $465,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $413 - $612	10 Added 0.11%	8,979 $473,000
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $542,552 - $696,955	-13,823 Reduced 60.65%	8,969 $386,000
Q2 2021 Aug 19, 2021	BUY	$35.91 - $40.68 $148,667 - $168,415	4,140 Added 22.2%	22,792 $893,000
Q1 2021 May 24, 2021	SELL	$33.49 - $37.77 $1.31 Million - $1.48 Million	-39,222 Reduced 67.77%	18,652 $676,000
Q4 2020 Feb 23, 2021	BUY	$33.47 - $42.56 $32,767 - $41,666	979 Added 1.72%	57,874 $2.13 Million
Q3 2020 Dec 09, 2020	BUY	$31.75 - $37.25 $25,844 - $30,321	814 Added 1.45%	56,895 $2.09 Million
Q2 2020 Aug 19, 2020	BUY	$30.12 - $36.54 $337,916 - $409,942	11,219 Added 25.01%	56,081 $1.83 Million
Q1 2020 May 27, 2020	SELL	$27.03 - $38.62 $174,235 - $248,944	-6,446 Reduced 12.56%	44,862 $1.46 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $5,925 - $6,724	-180 Reduced 0.35%	51,308 $2.01 Million
Q3 2019 Nov 19, 2019	BUY	$32.49 - $42.13 $543,297 - $704,497	16,722 Added 48.1%	51,488 $1.85 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $55,248 - $62,030	1,494 Added 4.49%	34,766 $1.51 Million
Q1 2019 May 20, 2019	BUY	$37.5 - $41.2 $119,962 - $131,798	3,199 Added 10.64%	33,272 $1.38 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $1.16 Million - $1.32 Million	30,073 New	30,073 $1.31 Million

Others Institutions Holding PFE

# of Institutions

3,259

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Resource Group, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Resource Group with notifications on news.

Account

Advisory Resource Group Pfizer Inc Transaction History